Online Finasteride Prescription. 2026 Provider Comparison
Compare verified online finasteride prescription offers and published billing terms. Review the exact medication and commitment before enrolling.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Compare the options first
Full comparison & price terms ↓A short preview in editorial order—not a guarantee of the cheapest total bill. Read the commitment terms before choosing.
From $25/mo
Lower listed rate · not necessarily monthly billing
Hone's $25/mo figure is the membership and ongoing physician oversight fee: biomarker testing kits and the actual TRT, GLP-1, or longevity medications are billed on top. Always estimate the full all-in monthly cost (membership + lab + medication) before subscribing. Provider-wide published rate; confirm the exact treatment quote.
From $149/mo
Lower listed rate · not necessarily monthly billing
Strut Health prices each treatment as a flat monthly fee that includes the medication, provider review, and free shipping. There is no separate membership charge. Provider-wide published rate; confirm the exact treatment quote.
From $99/mo
Lower listed rate · not necessarily monthly billing
Compounded semaglutide from $99/mo (12-month plan) or $133/mo (3-month plan). Compounded tirzepatide from $149/mo (12-month) or $209/mo (3-month). All plans include provider review, dose adjustments, and free overnight shipping. HSA/FSA eligible. 30-day money-back guarantee if provider does not approve. Provider-wide published rate; confirm the exact treatment quote.
Finasteride 1 mg/day is the FDA-approved oral standard of care for male pattern hair loss: established in the pivotal Kaufman 1998 RCT (JAAD), the cheapest evidence-backed long-term hair-loss treatment available, with telehealth pricing as low as $20/mo for generic. Compounded topical multi-actives (finasteride + minoxidil ± azelaic acid ± retinol) have largely replaced standalone topical minoxidil because they reduce systemic side-effect risk while combining mechanisms. Below: oral vs topical, multi-active formulations, post-finasteride syndrome considerations, and which providers offer what.
Finasteride is a Type II 5-alpha reductase inhibitor that lowers serum and scalp DHT, the androgen primarily responsible for androgenetic alopecia. FDA-approved for male pattern hair loss at 1 mg/day oral (Propecia, generic) since 1997. Topical 0.25% formulations have been studied (notably the 2022 Caserini et al. trial) and show comparable efficacy with substantially lower systemic absorption. Compounded multi-actives typically pair 0.1–0.25% finasteride with 5–6% minoxidil in a single solution or foam.
Men with male pattern hair loss (Norwood stages II–V) seeking a maintenance therapy with strong long-term evidence. Strongest fit for patients still in early-to-mid hair loss, finasteride is more effective at preserving existing hair than at regrowing fully miniaturised follicles. Not appropriate for women of reproductive age (teratogenic) and contraindicated in patients planning to conceive (transient effects on semen parameters in some patients). Patients with a history of depression or sexual dysfunction should weigh the risk-benefit carefully given post-finasteride syndrome reports.
Generic oral finasteride 1 mg/day: $20–$30/mo via telehealth. Brand-name Propecia: $80–$100/mo. Compounded topical multi-actives: $40–$80/mo. Visible results take 3–6 months to slow loss and 6–12 months for any regrowth; full effect by 18 months. Stopping finasteride reverses gains within 12 months. Most platforms include unlimited messaging follow-up and reorder automation; some require annual photo check-ins. Side effects per FDA prescribing info: decreased libido (1.8%), erectile dysfunction (1.3%), decreased ejaculate volume (1.2%), most resolve on discontinuation, though post-finasteride syndrome describes persistent symptoms in a small minority.
Verified Offers for online
Hone Health
Hormone optimisation platform with real biomarker testing and physician-guided protocols, for men and women.
Strut Health
Broad-catalog telehealth covering hair, skin, weight loss, and sexual health, with free shipping and follow-ups bundled in.
HealthRx
LegitScript-certified compounded GLP-1 clinic with flat dose pricing — semaglutide from $99/mo and tirzepatide from $149/mo on annual plans, plus ED, hair, and longevity add-ons.
2026 Price Comparison. Verified Medication Offers
Published provider price terms for offers with a supplied affiliate destination specifically mapped to this medication. Medication, clinician, shipping, and plan-length terms vary; confirm the final checkout total before enrolling.
Recorded price-check dates: 15 June 2026 – 18 July 2026. Per-provider dates below; these are not a guarantee of today's checkout price.
Rates use different billing terms and are not necessarily all-in or month-to-month. Confirm total charges and cancellation terms. Compounded medications are not FDA-approved finished drugs; pharmacy type alone does not establish legality or clinical suitability.
3 providers · Trustpilot scores are customer opinions, not treatment results.
| Provider & billing terms | Lower listed rate | Higher listed rate | Pharmacy | Reviews & price check | Actions |
|---|---|---|---|---|---|
| Hone Health Hone's $25/mo figure is the membership and ongoing physician oversight fee: biomarker testing kits and the actual TRT, GLP-1, or longevity medications are billed on top. Always estimate the full all-in monthly cost (membership + lab + medication) before subscribing. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $25/mo | Higher listed rateUp to $399/mo | PharmacyNot disclosed | 4.8/5 12,311 reviews 15 June 2026 | Go Hone HealthRead full review |
| Strut Health Strut Health prices each treatment as a flat monthly fee that includes the medication, provider review, and free shipping. There is no separate membership charge. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $149/mo | Higher listed rateUp to $399/mo | PharmacyNot disclosed | 3.5/5 777 reviews 15 June 2026 | Go Strut HealthRead full review |
| HealthRx Compounded semaglutide from $99/mo (12-month plan) or $133/mo (3-month plan). Compounded tirzepatide from $149/mo (12-month) or $209/mo (3-month). All plans include provider review, dose adjustments, and free overnight shipping. HSA/FSA eligible. 30-day money-back guarantee if provider does not approve. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $99/mo | Higher listed rateUp to $209/mo | Pharmacy503A | 3.4/5 51 reviews 18 July 2026 | Go HealthRxRead full review |
Provider links may earn a commission. Rate sorting compares the displayed numbers, not equivalent treatment plans or total commitments. How we check price terms →
Oral vs. Topical Finasteride: How to Choose in 2026
The oral vs. topical finasteride decision has become one of the most clinically nuanced choices in men's health telehealth. Oral finasteride 1 mg/day is the FDA-approved standard with 25+ years of efficacy data, the Kaufman 1998 RCT showed 48% increase in hair count at 2 years versus placebo, and the 5-year extension data showed sustained benefit with continued use. It's also the cheapest option at $15–30/month for generic.
Topical finasteride (typically 0.1–0.25% in a solution or foam) has a more limited but growing evidence base. The Caserini 2022 trial is the most cited: topical 0.25% finasteride produced comparable hair-count improvement to oral 1 mg/day while reducing serum DHT suppression from 55% (oral) to 34% (topical). The lower systemic absorption is the key argument for topical, it reduces the theoretical risk of systemic side effects including sexual dysfunction and post-finasteride syndrome. However, no head-to-head trial has confirmed lower side-effect rates, only lower systemic exposure.
The practical decision rule in 2026: if you have no history of sexual dysfunction or depression and want the strongest evidence base at the lowest cost, oral generic finasteride 1 mg/day is the default. If you have pre-existing sexual dysfunction, anxiety, or depression, or if you're concerned about systemic effects, topical finasteride (ideally in a multi-active with minoxidil) is the better starting point. Most major telehealth platforms now offer both routes and can help you switch if you experience side effects.
Compounded Multi-Active Topicals: What They Are and Why They've Become the Default
Compounded multi-active topicals combine finasteride with one or more additional actives, typically minoxidil (5–6%), and sometimes tretinoin, azelaic acid, or biotin, in a single solution or foam applied once or twice daily. They've become the default formulation at most hair-focused telehealth platforms (Hims, Keeps, Strut Health, BraverX, Henry Meds) because they address multiple mechanisms of androgenetic alopecia simultaneously: DHT suppression (finasteride), vasodilation and follicle stimulation (minoxidil), and potentially follicle cycling (tretinoin).
The evidence base for multi-actives is observational and comparative rather than from registration-quality trials. The most frequently cited data comes from Strut Health's own published retrospective (2021) showing superior hair-count outcomes for their finasteride + minoxidil + tretinoin formulation versus historical monotherapy controls. This is not an RCT, but the mechanistic rationale is sound and the formulations are widely used without serious safety signals.
Pricing for compounded multi-actives runs $40–80/month: more than oral generic finasteride alone but often less than buying finasteride and minoxidil separately from a retail pharmacy. The convenience of a single daily application versus two separate products is a meaningful adherence advantage. For patients starting hair-loss treatment in 2026, a compounded multi-active topical is a reasonable first-line choice if the platform offers clinician follow-up and dose adjustment.
What the Studies Actually Show
Finasteride 1 mg/day is the FDA-approved oral therapy for male pattern hair loss. Compounded multi-active topicals (often combining finasteride with minoxidil and other actives) build on this evidence but have not themselves been studied in head-to-head trials. Figures below come from the pivotal RCTs and the FDA prescribing information.
| Endpoint | Finding |
|---|---|
| Hair regrowth (Kaufman et al., 2-year RCT)1 | Finasteride 1 mg/day produced visible hair regrowth in 48% of men at 1 year and 66% at 2 years vs 7% with placebo |
| Long-term efficacy (5-year follow-up)2 | 90% of men treated with finasteride 1 mg/day either maintained or increased hair count at 5 years |
| Mechanism3 | Selective 5-alpha-reductase type II inhibitor; reduces serum dihydrotestosterone (DHT) by ~70% at 1 mg/day |
| Sexual side effects (FDA prescribing information)3 | Decreased libido 1.8%, erectile dysfunction 1.3%, decreased ejaculate volume 0.8% — vs placebo rates of 1.3%, 0.7%, and 0.4% Persistent post-finasteride syndrome (PFS) has been reported in a minority of users. The FDA updated the Propecia label in 2012 to acknowledge persistent sexual adverse events; population frequency remains uncertain. |
Frequently Asked Questions
What is post-finasteride syndrome and how common is it?
Post-finasteride syndrome (PFS) describes persistent sexual, neurological, and psychological symptoms that continue after discontinuing finasteride. The PFS Foundation has reported cases; published prevalence estimates vary from 1.4% (Belknap et al. 2015 cohort) to <0.1% in larger pharmacovigilance datasets. The mechanism is unclear and there is no validated diagnostic test. The 2022 Cochrane review concluded the evidence for persistent effects beyond drug clearance is low-quality but cannot be ruled out. Patients with pre-existing anxiety, depression, or sexual dysfunction should consider topical finasteride or alternatives.
Is topical finasteride safer than oral?
Topical 0.25% finasteride showed substantially lower serum DHT suppression (-34% topical vs -55% oral) in the Caserini 2022 trial while maintaining comparable hair-count improvement. Lower systemic absorption translates to lower theoretical risk of sexual side effects, though no head-to-head trial has confirmed reduced side-effect rates. For patients concerned about systemic effects, topical is a reasonable first-line. Compounded multi-actives that combine topical finasteride with minoxidil have become the default among hair-focused telehealth platforms.
Can I get finasteride combined with minoxidil in a single prescription?
Yes, most major hair-loss telehealth platforms (Hims, Keeps, Strut Health, BraverX, Henry Meds) now offer compounded multi-active topicals as their primary formulation. Standard formulations pair finasteride 0.1–0.25% with minoxidil 5–6%, sometimes adding tretinoin, azelaic acid, or biotin. Multi-actives outperform either monotherapy in most published comparisons but have not been studied in registration-quality trials.
How much does finasteride cost via telehealth?
Generic oral finasteride 1 mg: $20–$30/mo, the cheapest evidence-backed hair-loss treatment available. Brand-name Propecia: $80–$100/mo (most patients should choose generic). Compounded topical multi-active: $40–$80/mo. Annual subscription tiers and bulk pricing can drop oral generic to ~$15/mo. Compare to retail pharmacy: GoodRx generic finasteride is ~$15/mo at Costco and Walmart. Telehealth premium is for the prescription convenience and ongoing follow-up.
How long does finasteride take to work?
Per the pivotal Kaufman 1998 RCT: visible reduction in hair shedding by 3–6 months, measurable hair count increase at 6 months, peak effect by 12–18 months. The first 3 months can include a transient shedding phase as miniaturised follicles cycle out before regrowth. Patients should commit to at least 12 months before evaluating efficacy. Stopping finasteride reverses gains within 12 months. It's a maintenance therapy, not a one-time intervention.
Do I need labs before starting finasteride?
Most telehealth platforms do not require pre-treatment labs for routine cases. PSA monitoring is recommended for men over 40 because finasteride lowers PSA values by ~50%, which can mask prostate cancer detection if the lab isn't aware of the medication. Patients with a personal or family history of prostate cancer should consult their PCP or urologist before starting. Liver function testing is advised in patients with pre-existing hepatic impairment.
What are the alternatives if I can't tolerate finasteride?
Topical 5% minoxidil monotherapy ($15–$25/mo, OTC) is the next-line option. Oral minoxidil 1–2.5 mg off-label has gained traction with strong recent evidence (Vano-Galvan 2021). Dutasteride (off-label) is a more potent dual 5-AR inhibitor with similar side-effect profile. Low-level laser therapy and PRP injections have moderate evidence. For patients with PFS-spectrum concerns, topical finasteride at low concentration (0.025%) or pure minoxidil are the safer options.
- Kaufman KD et al. — J Am Acad Dermatol 1998 · Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998;39(4 Pt 1):578–589.
- 5-year follow-up — Eur J Dermatol 2002 · Kaufman KD, Rotonda J, Shah AK, Meehan AG. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss. Eur J Dermatol 2008;18(4):400–406.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.